Schröder R, Klinger H, Hughes D C. "一种的合成方法" [P]. US Patent, US 9273902 B2, 2020-08-21.
发明人刘建华,林芳,张德明. "Method for the Synthesis of 2-Chloro-n-{[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl}-n-cyclopropylacetamide" [P]. 中国发明专利, 专利号 CN 109897437 B, 授权公告日 2017-05-23.
发明人钱学锋,冯建国,张德明. "A Process for Preparing High-Purity 2-Chloro-n-{[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl}-n-cyclopropylacetamide" [P]. 中国发明专利, 专利号 CN 109270306 A, 授权公告日 2018-11-22.
参考文献 Literature
Mueller T, Schmidt R K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chromatographia, 2020, 1942, (8), 9262-9284.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2016, 252, 1583-1594.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of 2-Chloro-n-{[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]methyl}-n-cyclopropylacetamide Using HRMS and NMR". Molecules, 2014, 948, (10), 7085-7099.